This brief provides an overview of the role of PBMs in managing pharmacy benefits, discusses recent federal legislation focusing on several elements of PBM business practices, and explains the potential federal budgetary impact of this legislation, which would have a relatively modest impact on the federal deficit, based on available CBO estimates.
[Sponsored] Temperature-sensitive medications represent one of the most critical operational and regulatory challenges in modern pharmacy management. The post Best Automated Systems for Cold Chain Pharmacy Management appeared first on MedCity News.
There are a number of important ways AI will impact patients, providers and pharmacies in the coming year. They break down into three key areas. The post How AI Will Change the ePrescribing Experience for Patients, Providers and Pharmacies appeared first on MedCity News.
Hooman Hakami, who has served as a senior executive at GE Healthcare and Medtronic, has been appointed CEO
Are you a self-insured employer looking for ways to reduce healthcare spend? Join us for a webinar on December 11 in which HR executives will share their insights. The post Where Can Self-Insured Employers Look to Find Healthcare Savings? appeared first on MedCity News.
Cuts to Medicaid and other federal health programs proposed in President Donald Trump’s budget plan would rapidly push more than 300 financially struggling rural hospitals toward a fiscal cliff, according to researchers who track the facilities’ finances. The hospitals would be at a disproportionate risk of closure, service reductions, or ending inpatient care, according to…
KFF Health News Montana correspondent Katheryn Houghton discussed Medicaid work requirements on The Majority Report with Sam Seder on Aug. 7. Click here to watch Houghton on The Majority Report with Sam Seder. Read Houghton’s “Republicans Call Medicaid Rife With Fraudsters. This Man Sees No Choice but To Break the Rules.” and “New Medicaid Federal…
Innovation consortium has grown to 14 health systems with the addition of Yale New Haven Health System, Keck Medicine of USC, and Hartford HealthCare
Neurocrine Biosciences’ Crenessity is now FDA approved for treating classic congenital adrenal hyperplasia (CAH), a rare and potentially fatal endocrine disorder. The approval comes with a priority review voucher, which Neurocrine could sell for around $150 million. The post Neurocrine Lands FDA Nod for First New Treatment in Decades for Rare Endocrine Disorder appeared first…
With Medbridge’s new motion capture capabilities, patients can get more accurate feedback on therapeutic exercises while using their mobile phone or computer’s camera. The post Medbridge Announces New AI-Powered Motion-Capture Capabilities for MSK appeared first on MedCity News.